The demonstration of the interaction between HIF‐1, an established target for anticancer strategies [2], and NPM1, also associated with carcinogenesis, raises the interesting possibility that targeting this interaction could serve as an efficient means to curtail HIF‐1 activity and decrease cancer cell survival in hypoxic tumors. The gene discussed is HIF1A; the disease is cancer.